We are live on ! Find out more
ICCC icon

ImmuCell
ICCC

27 hedge funds and large institutions have $9.18M invested in ImmuCell in 2022 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 9 increasing their positions, 10 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

139% more capital inflows, than outflows

Capital inflows: $1.06M | Capital outflows: $443K

0.92% more ownership

Funds ownership: 11.37% → 12.29% (+0.92%)

7% less funds holding

Funds holding: 29 → 27 (-2)

10% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 10

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
27
Holders Change
-2
Holders Change %
-6.9%
% of All Funds
0.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
9
Reduced
10
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Shufro Rose & Co
Shufro Rose & Co
New York
+$553K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$320K
3
Morgan Stanley
Morgan Stanley
New York
+$88.9K
4
Bleichroeder LP
Bleichroeder LP
New York
+$76.1K
5
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors
North Carolina
+$8.63K

Top Sellers

Rank Fund Capital Flow
1
Overbrook Management Corp
Overbrook Management Corp
New York
-$255K
2
Renaissance Technologies
Renaissance Technologies
New York
-$113K
3
PCM
Perritt Capital Management
Illinois
-$30.3K
4
Essex Financial Services
Essex Financial Services
Connecticut
-$14.8K
5
Koshinski Asset Management
Koshinski Asset Management
Illinois
-$8.63K

ICCC Hedge Fund Activity: Q1 2022 in Review

27 of the 6,364 institutional investors tracked by Wall St. Rank reported a position in ImmuCell (ICCC) for Q1 2022, worth a combined $9.18M — up 30% from $7.04M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of ICCC and 0 opened new positions — a net loss of 2 holders — while 10 trimmed existing stakes and 9 added.

The largest buyer was Shufro Rose & Co, adding an estimated $553K. The largest seller was Overbrook Management Corp, cutting an estimated $255K.

  • 27 institutional investors held ImmuCell (ICCC) as of Q1 2022, down from 29 in Q4 2021.
  • Funds reported $9.18M of ImmuCell stock for Q1 2022, up 30% quarter-over-quarter.
  • 0 funds opened new ImmuCell positions in Q1 2022 and 2 closed out, a net change of -2 holders.
  • The largest ImmuCell buyer in Q1 2022 was Shufro Rose & Co, an estimated $553K added.
  • The largest ImmuCell seller in Q1 2022 was Overbrook Management Corp, an estimated $255K sold.

Based on aggregated 13F filings for Q1 2022.